Clinical outcome in children with culture-negative acute otitis media

Pediatric Infectious Disease Journal

Volumn 28, Issue 12, 2009, Pages 1105-1110

  Leibovitz, Eugene ^a   Nakash, Eyal ^a   Givon Lavi, Noga ^a   Greenberg, David ^a   Satran, Robert ^a   Raiz, Semion ^a   Piglansky, Lolita ^a   Leiberman, Alberto ^a   Dagan, Ron ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acute otitis media; Bacteriologic outcome; Clinical outcome; Middle ear fluid culture

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFACLOR; CEFDINIR; CEFTRIAXONE; CEFUROXIME AXETIL; GATIFLOXACIN; LEVOFLOXACIN;

ACUTE OTITIS MEDIA; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CHILD; DISEASE COURSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 74049137020     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181b20e7a     Document Type: Article

References (29)

1. Klein JO, Bluestone CD. Microbiology in Otitis Media in Infants and Children. 3rd ed. Philadelphia, PA: WB Saunders Company; 2001:79-101.
2. Pichichero ME. Recurrent and persistent otitis media. Pediatr Infect Dis J. 2000;19:911-916.
3. Leibovitz E, Raiz S, Piglansly L, et al. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics. Pediatr Infect Dis J. 1998;17:643-649.
4. Rayner MG, Zhang Y, Gorry MC, et al. Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA. 1998;279: 296-299.
5. Dingman JR, Rayner MG, Mishra S, et al. Correlation between presence of viable bacteria and presence of endotoxin in middle-ear effusions. J Clin Microbiol. 1998;36:3417-3419.
6. Palmu AAI, Saukkoriipi PA, Lahdenkari MI, et al. Does the presence of pneumococcal DNA in middle-ear fluid indicate pneumococcal etiology in acute otitis media? J Inf Dis. 2004;189:775-784.
7. Hall-Stoodley L, Hu FZ, Gieseke A, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA. 2006;296:202-211.
8. Heikkinen T, Thint M, Chomaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med. 1999;340:260-264. (Pubitemid 29063267)
9. Heikkinen T, Chonmaitree T. Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev. 2003;16:230-241.
10. Broides A, Leibovitz E, Dagan R, et al. Cytology of the middle ear fluid during acute otitis media. Pediatr Infect Dis J. 2002;21:57-60.
11. Barzilai A, Leibovitz E, Laver JH, et al. Dynamics of Interleukin-1 production in middle ear fluid during acute otitis media treated with antibiotics. Infection. 1999;27:173-176.
12. Barzilai A, Dekel B, Dagan R, et al. Cytokine analysis of middle ear effusions during acute otitis media: significant reduction in tumor necrosis factor alpha concentrations correlates with bacterial eradication. Pediatr Infect Dis J. 1999;18:301-303.
13. Leibovitz E, Dagan R, Laver JH, et al. Interleukin-8 in middle ear fluid during acute otitis media: correlation with aetiology and bacterial eradication. Arch Dis Child. 2000;82:165-168. (Pubitemid 30305715)
14. Satran R, Leibovitz E, Raiz S, et al. Clinical/otological score before and during treatment of acute otitis media. Acta Paediatr Scand. 2007;96:1814-1818 (Pubitemid 350132032)
15. American Academy of Pediatrics and American Academy of Family Physicians. Clinical practice guidelines. Subcommittee on management of acute otitis media. diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451-1465.
16. Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis J. 1996;15:980-985.
17. Dagan R, Abramson O, Leibovitz E, et al. Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J Inf Dis. 1997;176:1253-1259.
18. Dagan R, Leibovitz E, Fliss DM, et al. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother. 2000;44: 43-50.
19. Dagan R, Piglansky L, Fliss DM, et al. Bacteriologic response in acute otitis media: comparison between azithromycin, cefaclor and amoxicillin. In: Program and Abstracts of the 37th Conference on antibiotic agents and chemotherapy (ICAAC); 1997:346; Toronto, Ontario.
20. Dagan R, Johnson C, McLinn S, et al. Bacteriological and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J. 2000;19:95-104. (Pubitemid 30111402)
21. Leibovitz E, Piglansky L, Raiz S, et al. The bacteriologic efficacy of 1-day versus 3-day intramuscular ceftriaxone in the treatment of nonresponsive acute otitis media. Pediatr Infect Dis J. 2000;19:1040-1045.
22. Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J. 2001;20:829-837. (Pubitemid 32880315)
23. Piglansky L, Leibovitz E, Raiz S, et al. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Pediatr Infect Dis J. 2003;22:405-413.
24. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriological and clinical efficacy of oral gatifloxacin in the treatment of recurrent/non-responsive acute otitis media: an open-label, single center, non-comparative, double tympanocen-tesis study. Pediatr Infect Dis J. 2003;22:1-7.
25. Hoberman A, Dagan R, Leibovitz E, et al. Large dose amoxicillin/ clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children. Pediatr Infect Dis J. 2005;24: 525-532.
26. Arguedas A, Dagan R, Pichichero M, et al. An open-label, double tympa-nocentesis study of levofloxacin in the treatment of children with, or at high risk for, recurrent or persistent acute otitis media. Pediatr Infect Dis J. 2006;25:1102-1109. (Pubitemid 44900672)
27. Arguedas A, Dagan R, Leibovitz E, et al. A multicenter, open-label study of cefdinir in children with acute otitis media at high risk of persistent or recurrent infection. Pediatr Infect Dis J. 2006;25:211-218.
28. Leiberman A, Leibovitz E, Piglansky L, et al. The bacteriologic and clinical efficacy of trimethoprim/sulfamethoxazole in the treatment of acute otitis media in children. Pediatr Infect Dis J. 2001;20: 260-264. (Pubitemid 32240264)
29. Dagan R, Schneider S, Givon-Lavi N, et al. Failure to achieve early bacterial eradication increases clinical failure rate in acute otitis media in young children. Pediatr Infect Dis J. 2008;27:200-206.